Quote
L. Schlaffke, R. Rehmann, A.-K. Güttsches, M. Vorgerd, C. H. Meyer-Frießem, H. R. Dinse, E. Enax-Krumova, M. Froeling, and J. Forsting, "Evaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI," Journal of Clinical Medicine, vol. 13, no. 7, p. 1958, 2024.
Content
Background: Quantitative muscle MRI (qMRI) is a promising tool for evaluating and monitoring neuromuscular disorders (NMD). However, the application of different imaging protocols and processing pipelines restricts comparison between patient cohorts and disorders. In this qMRI study, we aim to compare dystrophic (limb-girdle muscular dystrophy), inflammatory (inclusion body myositis), and metabolic myopathy (Pompe disease) as well as patients with post-COVID-19 conditions suffering from myalgia to healthy controls.
Methods: Ten subjects of each group underwent a 3T lower extremity muscle MRI, including a multi-echo, gradient-echo, Dixon-based sequence, a multi-echo, spin-echo (MESE) T2 mapping sequence, and a spin-echo EPI diffusion-weighted sequence. Furthermore, the following clinical assessments were performed: Quick Motor Function Measure, patient questionnaires for daily life activities, and 6-min walking distance.
Results: Different involvement patterns of conspicuous qMRI parameters for different NMDs were observed. qMRI metrics correlated significantly with clinical assessments.
Conclusions: qMRI metrics are suitable for evaluating patients with NMD since they show differences in muscular involvement in different NMDs and correlate with clinical assessments. Still, standardization of acquisition and processing is needed for broad clinical use.
References
DOI 10.3390/jcm13071958